Stock Snapshot

Market Snapshot

BSE Sensex: 52553.41 0.44%
BSE 500: 21437.42 0.26%
BSE 200: 6826.58 0.23%
BSE 100: 16033.31 0.35%
BSE Mid-Cap: 22315.5 -0.36%
BSE Small-Cap: 24963.86 0.38%
BANKEX: 39422.84 0.40%
BSE IT Sector: 29419.42 0.63%
Nifty 50: 15691.4 -0.48%
Nifty 500: 13425.15 -0.63%
Nifty 200: 8307.25 -0.64%
Nifty 100: 15936.2 -0.56%
Nifty Midcap 100: 26776.35 -1.23%
Nifty Small 100: 9658.5 -0.53%
Nifty IT: 28611.35 0.57%
Nifty PSU Bank: 2422.25 -1.42%

News:

CRISIL upgrades, reaffirms cre...
Olectra Greentech Q4 PAT decli...
Adani Ports & Special Economic...
Bang Overseas Ltd leads losers...
Volumes spurt at Advanced Enzy...

Procter & Gamble Health Ltd NSE / BSE
Pharmaceuticals, Small Cap

Invest

17 Jun 2021 | 12:00 AM

5,766.65

-31.10 (-0.54%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

47.32%

Return (1Y)

Underperformed S&P BSE Healthcare by 6.5%
More Volatile

1.95%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 0.72%
Not so consistent

4/12

Months

underperformed S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

7,500

3,901

News & Announcements

Procter & Gamble Health standalone net profit declines 66.06% in the March 2021 quarter
42 days ago

Procter & Gamble Health standalone net profit declines 66.06% in the March 2021 quarter

07 - May - 2021 12:00 AM | 42 days ago

Net profit of Procter & Gamble Health declined 66.06% to Rs 15.77 crore in the quarter ended March 2021 as against Rs 46.46 crore during the previous quarter ended March 2020. Sales declined 3.93% to Rs 219.15 crore in the quarter ended March 2021 as against Rs 228.11 crore during the previous quarter ended March 2020.
Particulars Quarter Ended
Mar. 2021 Mar. 2020 % Var.
Sales 219.15 228.11 -4
OPM % 14.02 25.75 -
PBDT 33.77 69.00 -51
PBT 26.10 64.76 -60
NP 15.77 46.46 -66
Powered by Capital Market - Live News
Procter & Gamble Health to announce Quarterly Result
51 days ago

Procter & Gamble Health to announce Quarterly Result

27 - Apr - 2021 12:00 AM | 51 days ago

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 6 May 2021.
Powered by Capital Market - Live News
P&G Health Q2 PAT up 77% to Rs 67 cr
126 days ago

P&G Health Q2 PAT up 77% to Rs 67 cr

11 - Feb - 2021 12:00 AM | 126 days ago

The FMCG company said its profitability was primarily driven by lower travel and selling expenses due to Covid-19 pandemic.
Profit before tax jumped 70.1% to Rs 86.43 crore in Q2 December 2020 over Q2 December 2019. Current tax expense spiked 37% to Rs 19.03 crore in Q2 December 2020 over Q2 December 2019.
Commenting on company's Q3 performance, Milind Thatte, MD of Procter & Gamble Health said, The company continues to deliver consistent sales growth driven by a sustained demand for our quality and affordable vitamins, minerals, supplements and medicinal products. With the country gradually opening up and the markets showing a steady recovery in the health category, we will continue our focus on ensuring uninterrupted supplies while doubling down our efforts to increase reach through scientific communication, portfolio consumerization, and disease awareness and education.
Procter & Gamble (P&G) Health (formerly Merck) is engaged in manufacturing and marketing over-the-counter products, vitamins, minerals, and supplements.
Powered by Capital Market - Live News
Procter & Gamble Health standalone net profit rises 77.65% in the December 2020 quarter
127 days ago

Procter & Gamble Health standalone net profit rises 77.65% in the December 2020 quarter

11 - Feb - 2021 12:00 AM | 127 days ago

Net profit of Procter & Gamble Health rose 77.65% to Rs 67.88 crore in the quarter ended December 2020 as against Rs 38.21 crore during the previous quarter ended December 2019. Sales rose 1.46% to Rs 240.22 crore in the quarter ended December 2020 as against Rs 236.77 crore during the previous quarter ended December 2019.
Particulars Quarter Ended
Dec. 2020 Dec. 2019 % Var.
Sales 240.22 236.77 1
OPM % 36.95 20.70 -
PBDT 94.28 55.08 71
PBT 86.43 50.80 70
NP 67.88 38.21 78
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Merck Ltd has increased by 9.11% since past 3 Months
MF shareholding in Merck Ltd has decreased by -3.31% since past 3 Months
FII shareholding in Merck Ltd has increased by 45.22% since past 1 Year
MF shareholding in Merck Ltd has increased by 45.51% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Mar. 2021	Mar. 2020	% Var.
Sales	219.15	228.11	-4
OPM %	14.02	25.75	-
PBDT	33.77	69.00	-51
PBT	26.10	64.76	-60
NP	15.77	46.46	-66

Particulars	Quarter Ended
	Dec. 2020	Dec. 2019	% Var.
Sales	240.22	236.77	1
OPM %	36.95	20.70	-
PBDT	94.28	55.08	71
PBT	86.43	50.80	70
NP	67.88	38.21	78

General Notifications

My Notifications

Research Notifications

Procter & Gamble Health Ltd NSE / BSE Pharmaceuticals, Small Cap

5,766.65 -31.10 (-0.54%)

News & Announcements

Price vs Volume

Stock Trivia

Procter & Gamble Health Ltd NSE / BSE
Pharmaceuticals, Small Cap

5,766.65

-31.10 (-0.54%)